Press Releases :: VolitionRx Ltd (VNRX)

Jan 10, 2020 8:00 am EST

VolitionRx Completes Acquisition of Octamer GmbH

Dec 16, 2019 8:30 am EST

VolitionRx Limited Announces Strategic Acquisition

Dec 5, 2019 8:30 am EST

VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test

Dec 3, 2019 8:30 am EST

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

Nov 13, 2019 3:54 am EST

VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update

Nov 7, 2019 8:30 am EST

VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update

Oct 29, 2019 8:30 am EDT

Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video

Oct 25, 2019 12:00 pm EDT

Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC

Oct 18, 2019 8:30 am EDT

Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas

Oct 9, 2019 4:05 pm EDT

Volition Appoints Dr. Phillip Barnes to Board of Directors

rss_feed News RSS